FDA Approved: BASAGLAR KWIKPEN — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for BASAGLAR KWIKPEN (insulin glargine) from Eli Lilly and Company. The submission status indicates the supplement was a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• BASAGLAR KWIKPEN (Insulin glargine)

Snippet

SUPPL AP for BASAGLAR KWIKPEN (INSULIN GLARGINE)